Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients
- 1 August 1985
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 15 (2) , 167-170
- https://doi.org/10.1007/bf00257530
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Leydig cell function in patients with testicular cancer during and after chemotherapyInternational Journal of Andrology, 1983
- 30 Min ACTH Stimulation Test as Predictor of Hypothalamic‐Pituitary‐Adrenocortical FunctionActa Medica Scandinavica, 1980
- IMPROVED SINGLE-DOSE METYRAPONE TEST1980
- High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapyCancer Chemotherapy and Pharmacology, 1979
- DISCREPANCY BETWEEN ACTH AND CORTISOL RESPONSES TO INSULIN INDUCED HYPOGLYCAEMIAClinical Endocrinology, 1978
- EVALUATION OF 3 HOUR METYRAPONE TEST IN CHILDREN AND ADOLESCENTSClinical Endocrinology, 1977
- Pituitary-Adrenal Function in Ten Patients Receiving Medroxyprogesterone Acetate for True Precocious PubertyJournal of Clinical Endocrinology & Metabolism, 1970
- THRESHOLD ADRENOCORTICAL SENSITIVITY IN MAN AND ITS POSSIBLE APPLICATION TO CORTICOTROPHIN BIOASSAYThe Lancet, 1967
- Inhibition of Adrenal Protein Synthesis by Steroidsin Vitro1Endocrinology, 1967
- ISOLATION AND IDENTIFICATION OF 6β, 17α, 21-TRIHYDROXY-6α-METHYL-Δ4-PREGNENE-3,20-DIONE (21-ACETATE) FROM THE URINE OF HUMAN SUBJECTS TREATED WITH 6α-METHYL-17α-ACETOXYPROGESTERONEJournal of Endocrinology, 1962